Plasma-derived cfDNA to reveal potential biomarkers of response prediction and monitoring in non-small cell lung cancer (NSCLC) patients on immunotherapy.

被引：0
|
作者：
Vallnia, Francesco
Assayag, Karen
Ulz, Peter
Drake, Adam
Warsinske, Hayley
St John, John
Putcha, Girish
Cabel, Luc
Beaucaire-Danel, Sophie
Girard, Nicolas
Bidard, francois-Clement
机构：
[1] Freenome, San Francisco, CA USA
[2] Inst Curie, Paris, France
[3] Inst Curie, Dept Oncol, Paris, France
[4] Inst Curie, Inst Thorax Curie Montsouris, Paris, France
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
9588
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Potential predictors of immunotherapy-induced pneumonitis in non-small cell lung cancer (NSCLC)
    Pontoriero, Francesca Maria
    Pascale, Daniele
    Scalvenzi, Francesca
    Bao, Loc Carlo
    Bonanno, Laura
    Tine, Mariaenrica
    EUROPEAN RESPIRATORY JOURNAL, 2024, 64
  • [32] Advances in efficacy prediction and monitoring of neoadjuvant immunotherapy for non-small cell lung cancer
    Wang, Yunzhen
    Huang, Sha
    Feng, Xiangwei
    Xu, Wangjue
    Luo, Raojun
    Zhu, Ziyi
    Zeng, Qingxin
    He, Zhengfu
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [33] Plasma-derived immune-related factors as biomarkers of osimertinib resistance in EGFR-mutant non-small cell lung cancer patients
    Hydbring, Per
    TRANSLATIONAL LUNG CANCER RESEARCH, 2023, 12 (03) : 405 - 407
  • [34] Clinical implications of mixed response on prognosis of non-small cell lung cancer (NSCLC) patients treated with Immunotherapy
    Lee, Seyoung
    Um, Taegyu
    Lee, Jeeyeon
    Kim, Peter Haseok
    Yadav, Monica
    Chuchuca, Maria J.
    Chung, Liam Il-Young
    Chae, Young Kwang
    CANCER RESEARCH, 2024, 84 (06)
  • [35] Predictive biomarkers in the treatment of non-small cell lung cancer (NSCLC)
    Niho, Seiji
    CANCER SCIENCE, 2018, 109 : 423 - 423
  • [36] Plasma metabolite biomarkers for EGFR-mutated non-small cell lung cancer (NSCLC)
    Thamlikitkul, Lucksamon
    Manocheewa, Siriphan
    Limjiasahapong, Suphitcha
    Wanichthanarak, Kwanjeera
    Panya, Atikorn
    Poungvarin, Naravat
    Pomyen, Yotsawat
    Khoomrung, Sakda
    CANCER RESEARCH, 2024, 84 (06)
  • [37] Patterns of Response to Nivolumab in Patients with Non-Small Cell Lung Cancer (NSCLC)
    Schmid, S.
    Diem, S.
    Krapf, M.
    Li, Q.
    Flatz, L.
    Leschka, S.
    Desbiolles, L.
    Klingbiel, D.
    Jochum, W.
    Fruh, M.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2419 - S2420
  • [38] Clinical Predictive Markers of Response to Immunotherapy in Advanced Non-Small Cell Lung Cancer (NSCLC)
    Rhone, R.
    Raez, L.
    Dumais, K.
    Powery, H.
    Gentile, F.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (10) : S1083 - S1083
  • [39] PREDICTIVE SOLUBLE BIOMARKERS OF IMMUNE RESPONSE TO CHECKPOINT BLOCKADE IN NON-SMALL CELL LUNG CANCER (NSCLC) PATIENTS
    Raza, Afsheen
    Mohsen, Reyad
    Kanbour, Aladdin
    Gul, Abdul Rehman Zar
    Philip, Anite
    Vijayakumar, Suma
    Hydrose, Shereena
    Merhi, Maysaloun
    Inchakalody, Varghese
    Uddin, Shahab
    Al Homsi, Mohammed Ussama
    Dermime, Said
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A19 - A19
  • [40] eNose analysis for early immunotherapy response monitoring in non-small cell lung cancer
    Buma, Alessandra I. G.
    Muller, Mirte
    de Vries, Rianne
    Sterk, Peter J.
    van der Noort, Vincent
    Wolf-Lansdorf, Marguerite
    Farzan, Niloufar
    Baas, Paul
    van den Heuvel, Michel M.
    LUNG CANCER, 2021, 160 : 36 - 43
12345